MIAC is a clinical research organisation supporting international trials with advanced imaging and medical expertise. Originally founded as an academic corporation of the Basel University Hospital in 1995, MIAC today is a company tightly embedded in national and international research networks, driving the translation of novel imaging and post-processing modalities from their development to applications in clinical trials. MIAC is dedicated to advanced imaging, creating high impact scientific outcomes for your international trial, providing our expertise and commitment for personalized customer service. Tailor-made data analysis pipelines in Swiss quality standards ensure custom metrics and transparent gapless data safety for your imaging study. A highly specialized team of board-certified neuro-/radiologists, physicists, biomedical engineers, IT specialists, technicians and clinicians deliver tailor-made image data analysis services and international trial support to the leaders of the pharmaceutical industry. All MIAC services follow the high standards of Swiss quality and comply with the requirements of FDA – 21 CFR Part 11 & ICH – Good Clinical Practices.